These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 23614647)

  • 1. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review.
    Kumar S; Bhargava D; Thakkar A; Arora S
    Crit Rev Ther Drug Carrier Syst; 2013; 30(3):217-56. PubMed ID: 23614647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
    Buckley ST; Frank KJ; Fricker G; Brandl M
    Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances and patents in solid dispersion technology.
    Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid dispersions: a review.
    Dhirendra K; Lewis S; Udupa N; Atin K
    Pak J Pharm Sci; 2009 Apr; 22(2):234-46. PubMed ID: 19339238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview on Recent Patents and Technologies on Solid Dispersion.
    Kaushik R; Budhwar V; Kaushik D
    Recent Pat Drug Deliv Formul; 2020; 14(1):63-74. PubMed ID: 31951172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
    Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
    Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanonization techniques to overcome poor water-solubility with drugs.
    Da Silva FLO; Marques MBF; Kato KC; Carneiro G
    Expert Opin Drug Discov; 2020 Jul; 15(7):853-864. PubMed ID: 32290727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCS class IV drugs: Highly notorious candidates for formulation development.
    Ghadi R; Dand N
    J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation.
    Patil H; Tiwari RV; Repka MA
    AAPS PharmSciTech; 2016 Feb; 17(1):20-42. PubMed ID: 26159653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
    Karwal R; Garg T; Rath G; Markandeywar TS
    Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents.
    Alshehri S; Imam SS; Hussain A; Altamimi MA; Alruwaili NK; Alotaibi F; Alanazi A; Shakeel F
    Drug Deliv; 2020 Nov; 27(1):1625-1643. PubMed ID: 33207947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application research of hot-melt extrusion in preparation of solid dispersion].
    Chen MW; Chen WR; Chen TK; Chen RE; Wang YT
    Yao Xue Xue Bao; 2012 Feb; 47(2):163-7. PubMed ID: 22512025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inorganic matrices: an answer to low drug solubility problem.
    Perioli L; Pagano C
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1559-72. PubMed ID: 23061519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APPLICATION OF VARIOUS POLYMERS AND POLYMERS BASED TECHNIQUES USED TO IMPROVE SOLUBILITY OF POORLY WATER SOLUBLE DRUGS: A REVIEW.
    Muhammad Sarfraz R; Bashir S; Mahmood A; Ahsan H; Riaz H; Raza H; Rashid Z; Atif Raza S; Asad Abrar M; Abbas K; Yasmeen T
    Acta Pol Pharm; 2017 Mar; 74(2):347-356. PubMed ID: 29624239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical solid dispersion technology: a strategy to improve dissolution of poorly water-soluble drugs.
    Kumar S; Gupta SK
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):111-21. PubMed ID: 23331062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degrees of order: A comparison of nanocrystal and amorphous solids for poorly soluble drugs.
    Peltonen L; Strachan CJ
    Int J Pharm; 2020 Aug; 586():119492. PubMed ID: 32505579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Compendium of Bioavailability Enhancement
    Sharma S; Kumari N; Garg D; Chauhan S
    Pharm Nanotechnol; 2023; 11(4):324-338. PubMed ID: 36892113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N; Tadikonda R
    Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs).
    Kankala RK; Xu PY; Chen BQ; Wang SB; Chen AZ
    Adv Drug Deliv Rev; 2021 Sep; 176():113846. PubMed ID: 34197896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.